Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
- Deadline
- August 11, 2027
- Funding
- Up to $150,000
- Geography
- National
- Funder
- National Institutes of Health
Grant Overview
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary…